Wednesday, May 7, 2025

Latest

Canopy Growth Investment Results In $1.0 Billion Impairment For Constellation Brands

Canopy Growth Corp (TSX: WEED) continues to cause problems for Constellation Brands (NYSE: STZ). The latter this morning reported its second quarter 2023 financial results, and as we had predicted, was forced to take a significant write-down on the value of its Canopy investment.

The ongoing poor performance of the cannabis company hit a crescendo in the most recent quarter, when the company was forced to record impairments of $1.73 billion in goodwill, which represents all goodwill associated with the firms cannabis operations. The result was a net loss for the quarter of $2.08 billion – which then hit Constellation hard.

Due to the method in which Constellation records its investment in Canopy, referred to as the equity method, that impairment trickled down to Constellation as well. For the three months ended August 31, 2022, Constellation was forced to recognize a $650.7 million loss on its books from Canopy, of which $460.8 million is a direct result of Canopy conducting those impairments.

However, further impairments were also required during the quarter due to the falling share price of Canopy, the uncertainty of the stock price recovering, and what Constellation refers to as the uncertainty of US federal cannabis. The result, is a $1,060.4 million impairment was taken by Constellation in the second quarter of fiscal 2023 – on top of the loss recorded for the firms quarterly performance.

The firms equity method investments as a result have now fallen below the $1.0 billion level, to that of $833.4 million.

In terms of the quarter as a whole, Constellation Brands recognized revenues of $2,864.3 million, and gross profits of $1,325.9 million. After the impairments it was forced to take as a result of its initial $4.4 billion investment in Canopy that is now worth a fraction of that figure, the company recorded a net loss of $1,140.7 million for the second quarter, reflecting a loss per share of $6.30.

Constellation Brands last traded at $235.95 on the NYSE.


Information for this briefing was found via SEC.gov, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Related News

Bruce Linton: Will Cannabis Be Descheduled Under Biden? – The Daily Dive

Today on the Daily Dive, we get the opportunity to sit down with Bruce Linton,...

Tuesday, February 9, 2021, 01:30:00 PM

Canopy Growth Announces Five New Ontario Retail Locations

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) is increasing its focus on retail operations across...

Monday, January 6, 2020, 08:48:06 AM

Canopy Growth Sees Numerous Analysts Lower Price Targets

On Friday, Canopy Growth (TSX: WEED) (NYSE: CGC) reported results before the market opened, missing...

Monday, June 1, 2020, 06:33:13 PM

Canopy Growth To Propose Share Consolidation Of Up To 1 For 15 Shares

Canopy Growth (TSX: WEED) is set to seek approval for a share consolidation, following the...

Friday, July 14, 2023, 09:43:15 AM

Canopy’s Quarter in Charts

Whenever there’s a negative margin, those of us in the financial content biz like to...

Sunday, November 17, 2019, 08:58:03 AM